News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Deals
Henry Schein, Inc. To Buy Darby Group Assets For $52 Million
June 21, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK, June 21 (Reuters) - Henry Schein Inc. (HSIC.O: Quote, Profile, Research), a supplier of dental and medical products, said on Wednesday it will acquire three companies from closely held Darby Group Cos. for about $51.5 million in cash.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
MORE ON THIS TOPIC
Podcast
Another Gene Therapy Death; Biopharma M&A Picks Up; a Vaccine Board of Vaccine Skeptics
June 18, 2025
·
1 min read
·
Heather McKenzie
Mergers & acquisitions
Biopharma Deal Premiums Paint Picture of Cutthroat Negotiations
June 18, 2025
·
4 min read
·
Annalee Armstrong
Mergers & acquisitions
Lilly Validates Gene Editing Space With $1.3B Verve Buy, But Analysts Are Skeptical
June 17, 2025
·
3 min read
·
Annalee Armstrong
Mergers & acquisitions
A String of Biopharma Deals Has Piqued Analyst Interest in an M&A Return
June 17, 2025
·
3 min read
·
Annalee Armstrong